Combined use of angiogenesis inhibitor and taxane

Details for Australian Patent Application No. 2009210098 (hide)

Owner Eisai R & D Management Co., Ltd.

Inventors Yamamoto, Yuji

Agent FB Rice

Pub. Number AU-A-2009210098

PCT Pub. Number WO2009/096377

Priority 61/024,359 29.01.08 US

Filing date 27 January 2009

Wipo publication date 6 August 2009

International Classifications

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/47 (2006.01) - Quinolines

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

5 August 2010 PCT application entered the National Phase

  PCT publication WO2009/096377 Priority application(s): WO2009/096377

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009210104-Abnormal operation detection device

2009210093-Refrigeration apparatus